X4 PharmaceuticalsXFOR
13F holders, Q3 2025 (September 30)2holders
0new positions
0sold out
$3.42avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding X4 Pharmaceuticals Inc. (XFOR) in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were NEA Management Company, LLC ($7.6M) and Acorn Capital Advisors, LLC ($935K).
- Company
- X4 Pharmaceuticals Inc.
- CUSIP
- 98420X103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1,853,803 shares bought, net +1,853,803 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| NEA Management Company, LLC | 0.42% | Add +347.1% | 2,233,743 | $7.6M |
| Acorn Capital Advisors, LLC | 0.47% | Add +77.8% | 273,349 | $935K |
"% of holder's portfolio" is XFOR's weight in each manager's 13F, not the share of X4 Pharmaceuticals Inc. the manager owns.